| Autor: |
Barry, Michael J., Nicholson, Wanda K., Silverstein, Michael, Cabana, Michael D., Chelmow, David, Coker, Tumaini Rucker, Davis, Esa M., Donahue, Katrina E., Jaén, Carlos Roberto, Li, Li, Ogedegbe, Gbenga, Rao, Goutham, Ruiz, John M., Stevermer, James, Tsevat, Joel, Underwood, Sandra Millon, Wong, John B. |
| Předmět: |
|
| Zdroj: |
JAMA: Journal of the American Medical Association; 9/19/2023, Vol. 330 Issue 11, p1074-1082, 9p |
| Abstrakt: |
Importance: Hypertensive disorders of pregnancy are among the leading causes of maternal morbidity and mortality in the US. The rate of hypertensive disorders of pregnancy has been increasing from approximately 500 cases per 10 000 deliveries in 1993 to 1021 cases per 10 000 deliveries in 2016 to 2017. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertensive disorders of pregnancy. Population: Pregnant persons without a known diagnosis of a hypertensive disorder of pregnancy or chronic hypertension. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for hypertensive disorders in pregnancy with blood pressure measurements has substantial net benefit. Recommendation: The USPSTF recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy. (B recommendation) This 2023 Recommendation Statement from the US Preventive Services Task Force recommends screening for hypertensive disorders in pregnant persons with blood pressure measurements throughout pregnancy (B recommendation). [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
